(Q35581973)

9 August 2017

0 references

Paradoxical increase of pulmonary vascular resistance during testing of inhaled iloprost (English)

1 reference

9 August 2017

Emmel M

1

1 reference

9 August 2017

Keuth B

series ordinal

2

1 reference

9 August 2017

Schickendantz S

series ordinal

3

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

90

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

e2

1 reference

Long term treatment of pulmonary arterial hypertension with beraprost, an oral prostacyclin analogue

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768033

Progress in, and future prospects for, the treatment of primary pulmonary hypertension

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768033

Current management of primary pulmonary hypertension

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768033

New and experimental therapies for pulmonary hypertension

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768033

Long term inhalation of iloprost in a child with primary pulmonary hypertension: an alternative to continuous infusion

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768033

Recommendations on the management of pulmonary hypertension in clinical practice

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768033

High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768033

Medical therapy of pulmonary hypertension. The prostacyclins

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768033

Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768033

Primary pulmonary hypertension in children: clinical characterization and survival.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768033

26 September 2018

Identifiers

DOI

10.1136/HEART.90.1.E2

1 reference

9 August 2017

1 reference

9 August 2017

1 reference